Influence of Declining Kidney Function on Insulin Dosage in Type 1- and Type 2-Diabetic Patients;Einfluss der nachlassenden Nierenfunktion auf die Insulindosis bei Typ 1- und Typ 2-Diabetikern

Diabetologie und Stoffwechsel

Volumn 1, Issue 5, 2006, Pages 311-318

  Vogt, C ^a   Hasslacher, C ^a   Dreyhaupt, J ^b  

^a StJosefs Krankenhaus Heidelberg   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Diabetes; diabetic nephropathy; insulin dosage; renal insufficiency

Indexed keywords

EID: 36849079953     PISSN: 18619002     EISSN: 18619010     Source Type: Journal    
DOI: 10.1055/s-2006-947260     Document Type: Article

References (29)

1. Rosenkranz R, Profozic V, MeteIko Z, Mrzljak V, Lange C, Malerczyk V. Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment. Diabetologia 1996; 39: 1617–1624
2. Jönsson A, Rydberg T, Sterner G, Melander A. Pharmacokinetics of glibenclamide and its metaboli|tes in diabetic patients with impaired renal function. Eur J Clin Pharmacol 1998; 53: 429–435
3. Hasslacher C, Wittmann W. Schwere Hypogly$amien bei Diabetikern mit eingeschränkter Nierenfunktion. DMW 2003; 128: 253–256
4. Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT. Impact of diabetic nephropathy on pharmacodynamic and pharmacokinetic properties of insulin in type 1 diabetic patients. Diab Care 2001; 24: 886–890
5. Svensson M, Yu ZW, Eriksson JW. A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephropathy. Eur. J. Clin. Invest. 2002; 32: 100–109
6. Rabkin R, Ryan MP, Duckworth WC. The renal metabolism of insulin. Diabetologia 1984;27:351–357
7. Rubenstein AH, Mako ME, Horwitz DL. Insulin and the kidney. Nephron 1975; 15:306–326
8. Arem R. Hypoglycemia associated with renal failure. Endocrinol Me-tab Clin North Am 1989;18:103–121
9. Mühlhauser I, Toth G, Sawicki PT, Berger M. Severe hypoglycemia in type I diabetic patients with impaired kidney function. Diab Care 1991: 14:344–346
10. DeFronzo RA. Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 67: 563–568
11. Charlesworth JA, Kriketos AD, Jones JE, Erlich JH, Campell LV, Peake PW. Insulin resistance and postprandial triglyceride levels in primary renal disease. Metabolism Clinical and Experimental 2005; 54: 821–828
12. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 1998; 53: 1343–1347
13. Alvestrand A. Carbohydrate and insulin metabolism in renal failure. Kidney Int 1997; 52 Suppl 62: 48–52
14. De Fronzo RA, Alvestrand A. Glucose intolerance in uremia: Site and mechanism. Am J Clin Nutr 1980; 3: 1438–1445
15. Castellino PAS, Luzi L, Barr JG, Smith DJ, Peterides A, Giordano M, Carroll C, Deferonzo RA. Glucose and amino acid metabolism in chronic renal failure: Effect of insulin and amino acids. Am J Physiol 1992; 262: 168–176
16. Stenvinkel P, Lonnqvist F, Schalling M. Molecular studies of leptin: implications for renal disease. Nephrol Dial Transplant 1999; 14: 103–112
17. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelmann BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409–2415
18. Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 1989; 143: 3949–3955
19. Kraus L, Traxinger R, Kraus AP Jr. Uremia and insulin resistance: N-car-barmoyl-asparagine decreases insulin-sensitive glucose uptake in rat adipoctes. Kindney Int 2004; 65: 881–887
20. Hatch FE, Watt MF, Kramer NC, Parrish AE, Howe JS. Diabetic glumeru-losclerosis, A long term follow-up study based on renal biopsies. Am J Med 1961; 31: 216–230
21. Altmann JJ, Kuntziger H, Dupuy CA. Prise en charge meacute;tabolique de I'insuffisance reńale terminale du diabétique. Journées annuelles de Diabétologie de I'H$tel-Dieu. Flammarion Medecine-Sciences, 1989: 261–272
22. Charpentier G, Riveline JP, Varroud-Vial M. Management of drugs affecting blood glucose in diabetic patients with renal failure. Diabetes & Metabolism 2000; 26: 73–85
23. Biesenbach G, Raml A, Schmekal B, Eichbauer-Sturm G. Decreased insulin requirement in relation to GFR in nephropathy type 1 and insulin-treated type 2 diabetic patients. Diabetes Med 2003; 20: 642–645
24. Gerich JE, Meyer C, Woerle HJ et al. Renal Gluconeogenesis. Its importance in human glucose homeostasis. Diabetes Care 2001; 24: 382–391
25. Stumvoll M, Meyer CA, Mitrakou C, Nadkarni V, Gerich JE. Renal glucose production and utilization: new aspects in humans. Diabetologia 1997;40:749–757
26. Cersosimo E, Garlick P, Ferretti J. Renal glucose production during insulin-induced hypoclycemia in humans. Diabetes 1999; 48: 261–266
27. Meyer C, Doston JM, Gerich JE. Role of the human kidney in glucose conterregulation. Diabetes 1999; 48: 943–948
28. Cersosimo E, Garlick P, Ferretti J. Abnormal glucose handling by the kidney in response to hypoglycemia in type 1 diabetes. Diabetes 2001; 50:2087–2093
29. Gerich JE. Lilly Lecture 1988: glucose conterregulation and its impact on diabetes mellitus. Diabetes 1988; 37: 1608–1617